GGrantIndex
Sort

53,477 grants matching addiction

Hypocretinergic control of cocaine abuse

$482,482
Tamas L Horvath · Yale University · R01 · FY2022 · DA

Hypocretinergic control of cocaine abuse

$482,481
Tamas L Horvath · Yale University · R01 · FY2020 · DA

Hypocretinergic control of cocaine abuse

$482,480
Tamas L Horvath · Yale University · R01 · FY2021 · DA

Hypocretinergic control of cocaine abuse

$482,480
Tamas L Horvath · Yale University · R01 · FY2019 · DA

Smoking Cessation Intervention for American Indian Women Experiencing Intimate Partner Violence

$482,467
Patricia Nez Henderson · Black Hills Ctr/American Indian Health · S06 · FY2022 · GM

Mapping opioid-dependence state transitions across structural, functional, and transcriptomic topologies

$482,452
Julie A Blendy · University Of Pennsylvania · R01 · FY2022 · DA

Evaluation of Novel Pharmacotherapies for the Treatment of Opioid Dependence

$482,436
Sharon L. Walsh · University Of Kentucky · R01 · FY2014 · DA

Modulation of local adenosine signaling to attenuate fracture pain

$482,293
Shyni Varghese · Duke University · R01 · FY2023 · AR

Targeting mTORC1 translational control in FOXO1 fusion positive rhabdomyosarcoma

$482,283
Amit J. Sabnis · University Of California, San Francisco · R01 · FY2025 · CA

Integrative Genetics and Genomics

$482,281
Vivek Philip · Jackson Laboratory · P50 · FY2019 · DA

Determinants of Elderly Health: The Role of Place-Based Factors

$482,267
Amy N. Finkelstein · Massachusetts Institute Of Technology · R37 · FY2020 · AG

INDIVIDUALIZING TREATMENT FOR ADDICTED SMOKERS

$482,260
Harvard University (Medical School) · R01 · FY2002 · DA

Optimizing Pharmacotherapy for Bipolar Alcoholics

$482,253
Ihsan M Salloum · University Of Miami School Of Medicine · R01 · FY2010 · AA

Extended Tobacco Dependence Intervention in Buprenorphine Treatment

$482,237
Sharon M. Hall · University Of California, San Francisco · P50 · FY2011 · DA

Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving, Reactivity & Use

$482,213
Michael E Saladin · Medical University Of South Carolina · R01 · FY2015 · DA

Opiate Dependence: Combined Naltrexone/Behavior Therapy

$482,193
Maria A Sullivan · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2008 · DA

Targeting mTORC1 translational control in FOXO1 fusion positive rhabdomyosarcoma

$482,175
Amit J. Sabnis · University Of California, San Francisco · R01 · FY2024 · CA

Therapeutic Community and Opioid Replacement Therapy

$482,145
University Of California San Francisco · R01 · FY2002 · DA

Matching Services to Client Needs in Drug Court

$482,138
Treatment Research Institute, Inc. (Tri) · R01 · FY2003 · DA

An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder

$482,109
Anne Marie Quinn · Montana Molecular, Llc · R44 · FY2021 · DA

Effectiveness of Technology Assisted Diffusion For Evidence Based Treatment

$482,072
Sarah Hunter · Rand Corporation · R01 · FY2014 · AA

A Multi-Method Study of Extreme Alcohol Drinkers in the Lab and in Real-Life: Increasing Precision of Assessments of Extreme Drinking Determinants

$482,037
Timothy J Trull · University Of Missouri-Columbia · R01 · FY2024 · AA

Predicting AUD development, risk and resilience phenotypes through integration of multi-modal COGA data

$482,025
Sivan Kinreich · Suny Downstate Medical Center · R01 · FY2025 · AA

Predicting AUD development, risk and resilience phenotypes through integration of multi-modal COGA data

$482,025
Sivan Kinreich · Suny Downstate Medical Center · R01 · FY2024 · AA

HCC-Small: Protein Design Through Massively Distributed Video Games

$482,000
Zoran Popovic · University Of Washington · · FY2008 · CSE